Diagnosis
FDA Allows Marketing of First A1c Test Labeled for Diagnosing Diabetes
May 23, 2013 (FDA) — Today the U.S. Food and Drug Administration announced that it is allowing marketing of the COBAS INTEGRA 800 Tina-quant HbA1cDx assay (Tina-quant HbA1cDx assay) for the diagnosis of diabetes by health care professionals. This is the first HbA1c test that FDA has allowed to be marketed for this use.
The HbA1c tests, or A1c tests, currently on the market are FDA-cleared for monitoring a patient's blood glucose (sugar) control, but not for diagnosing diabetes
Continue reading "FDA Allows Marketing of First A1c Test Labeled for Diagnosing Diabetes"
Email this Hypertension Traced to Source in Brain, Triggering New Paradigm for Hypertension Treatment
December 17, 2012 (Newswise) — When the heart works too hard, the brain may be to blame, says new Cornell University research that is changing how scientists look at high blood pressure (hypertension). The study, published in the Journal of Clinical Investigation in November, traces hypertension
Email this Heart Calcium Scan Predictive of Diabetes-Related Death from Cardiovascular Disease
December 20, 2012 (Newswise) — People with Type 2 diabetes have two to four times the risk of cardiovascular disease compared to people without the disease. The best way for doctors to predict which diabetes patients are at the greatest risk for heart disease is to use a coronary artery calcium (CAC) test in addition to the most commonly used assessment tool, according to rese
Email this Hold the Diet Soda? Sweetened Drinks Linked to Depression, Coffee Tied to Lower Risk
January 9, 2013 (Newswise) — New research suggests that drinking sweetened beverages, especially diet drinks, is associated with an increased risk of depression in adults while drinking coffee was tied to a slightly lower risk. The study was released today and will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013.
< Email this Most-Used Diabetes Drug Works in Different Way than Previously Thought
January 7, 2013 (Perelman School of Medicine) — A team, led by senior author Morris J. Birnbaum, MD, PhD, the Willard and Rhoda Ware Professor of Medicine, with the Institute for Diabetes, Obesity, and Metabolism, Perelman School of Medicine, University of Pennsylvania, found that the diabetes drug metformin works in a different way than previously understood. Their research in mice found that metformin suppresses the liver hormone glucagon's
Continue reading "Most-Used Diabetes Drug Works in Different Way than Previously Thought"
Email this 
You are subscribed!
You are subscribed!
You are subscribed!
dLife Weekly Poll
Do you use a computer to help track your blood glucose levels?
